CA2107475A1 - Proteine fixatrice du facteur de croissance apparente a l'insuline isole du tissu osseux humain - Google Patents

Proteine fixatrice du facteur de croissance apparente a l'insuline isole du tissu osseux humain

Info

Publication number
CA2107475A1
CA2107475A1 CA002107475A CA2107475A CA2107475A1 CA 2107475 A1 CA2107475 A1 CA 2107475A1 CA 002107475 A CA002107475 A CA 002107475A CA 2107475 A CA2107475 A CA 2107475A CA 2107475 A1 CA2107475 A1 CA 2107475A1
Authority
CA
Canada
Prior art keywords
igfbp
hbd
igf
bone
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002107475A
Other languages
English (en)
Inventor
Subburaman Mohan
David J. Baylink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2107475A1 publication Critical patent/CA2107475A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
CA002107475A 1991-04-19 1992-04-15 Proteine fixatrice du facteur de croissance apparente a l'insuline isole du tissu osseux humain Abandoned CA2107475A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68835391A 1991-04-19 1991-04-19
US688,353 1991-04-19

Publications (1)

Publication Number Publication Date
CA2107475A1 true CA2107475A1 (fr) 1992-10-20

Family

ID=24764088

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002107475A Abandoned CA2107475A1 (fr) 1991-04-19 1992-04-15 Proteine fixatrice du facteur de croissance apparente a l'insuline isole du tissu osseux humain

Country Status (11)

Country Link
EP (1) EP0580752A4 (fr)
JP (1) JP2527896B2 (fr)
KR (1) KR0129864B1 (fr)
AU (1) AU658187B2 (fr)
CA (1) CA2107475A1 (fr)
CZ (1) CZ283601B6 (fr)
FI (1) FI934588A0 (fr)
HU (1) HUT70297A (fr)
NO (1) NO933742L (fr)
RU (1) RU2114120C1 (fr)
WO (1) WO1992018154A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2100083A1 (fr) 1991-01-08 1992-07-09 Michael C. Kiefer Proteine se liant au facteur de croissance de substances apparentees a l'insuline (igfbp)
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US6124259A (en) * 1993-01-28 2000-09-26 Celtrix Pharmaceuticals, Inc. Method for treating ophthalmic disorders with IGFBP
CA2195474A1 (fr) * 1994-07-20 1996-02-01 Cedo Martin Bagi Complexe igf/igfbp pour promouvoir la formation de tissu osseux et pour reguler le remodelage osseux
PT1486565E (pt) 1995-10-11 2008-02-28 Novartis Vaccines & Diagnostic Combinação de pdgf, kgf, igf e igfbp para cicatrização de ferimentos
AR032028A1 (es) 2001-01-05 2003-10-22 Pfizer Anticuerpos contra el receptor del factor de crecimiento similar a insulina
US10212614B2 (en) * 2015-12-31 2019-02-19 Facebook, Inc. Igniting network nodes in a multi-hop wireless network
EP3397644A4 (fr) * 2015-12-31 2018-12-19 Siemens Healthcare Diagnostics Inc. Concentré de protéine de liaison de facteur de croissance humain de type insuline non recombinée

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7907958A (nl) * 1979-10-30 1981-06-01 Wijn Adriaan Jacques De Kar of onderstel voorzien van opklapbare wielen.
IL68218A (en) * 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
ES2063033T3 (es) * 1987-04-28 1995-01-01 Boehringer Mannheim Gmbh Empleo de igf-ii en el tratamiento de la enfermedades de los huesos.

Also Published As

Publication number Publication date
JPH06501270A (ja) 1994-02-10
EP0580752A4 (en) 1994-08-24
CZ219093A3 (en) 1994-12-15
FI934588A (fi) 1993-10-18
RU2114120C1 (ru) 1998-06-27
NO933742L (no) 1993-10-18
KR0129864B1 (en) 1998-04-09
AU658187B2 (en) 1995-04-06
HUT70297A (en) 1995-09-28
JP2527896B2 (ja) 1996-08-28
AU1784492A (en) 1992-11-17
FI934588A0 (fi) 1993-10-18
CZ283601B6 (cs) 1998-05-13
HU9302942D0 (en) 1994-01-28
WO1992018154A1 (fr) 1992-10-29
EP0580752A1 (fr) 1994-02-02

Similar Documents

Publication Publication Date Title
US5736511A (en) Methods for treatment using acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
AU623447B2 (en) Binding protein for insulin-like growth factors
EP0424416B1 (fr) Sous-unite labile aux acides d'un complexe proteique de liaison du facteur de croissance analogue a l'insuline
EP0546110B1 (fr) Nouvelle proteine de liaison de facteur de croissance analogue a l'insuline igfbp-5
EP0831871B1 (fr) Facteur similaire a la relaxine, ses procedes et emplois
IL85983A (en) Human somatomedin carrier protein subunits, antibodies against them, pharmaceutical compostitions containing them and their use in the preparation of medicaments
Perkel et al. An inhibitory insulin-like growth factor binding protein (In-IGFBP) from human prostatic cell conditioned medium reveals N-terminal sequence identity with bone derived In-IGFBP
AU658187B2 (en) Human bone derived insulin like growth factor binding protein
EP0546074B1 (fr) Matiere genetique codant la ifgbp-5
EP2252314B1 (fr) Agoniste de la leptine et méthodes d utilisation
US5453489A (en) Polypeptide fragments of fibronectin which can modulate extracellular matrix assembly
JPH11506337A (ja) 骨刺激因子
WO1999049894A1 (fr) Antagonistes du gene 6 specifique de l'arret de croissance, et leur utilisation contre des troubles insulinoresistants
WO1994025057A1 (fr) Antagonistes de la liaison du kgf derives du recepteur de kgf
US5693754A (en) Inhibitory binding protein for insulin-like growth factors
US7125961B2 (en) Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US6329500B1 (en) Transforming growth factor-β binding site
AU638935B2 (en) Acid-labile subunit (als) of insulin-like-growth factor (igf)binding protein complex

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued